Our new preprint is out: "Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City" with Harm van Bakel Mia Sordillo
New study of Covid seroprevalence in New York by and team; finds that 1:5 New Yorkers likely already had SARS-CoV-2 by late April and the infection fatality rate in New York City was about 0.7%.
One in five seroprevalence rate of #SarsCov2 in #NewYork by April 19th. medRxiv data from ⁦
Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City #medRxiv